89 related articles for article (PubMed ID: 8553857)
21. Coordinated regulation of hyaluronan and aggrecan content in the articular cartilage of immobilized and exercised dogs.
Haapala J; Lammi MJ; Inkinen R; Parkkinen JJ; Agren UM; Arokoski J; Kiviranta I; Helminen HJ; Tammi MI
J Rheumatol; 1996 Sep; 23(9):1586-93. PubMed ID: 8877929
[TBL] [Abstract][Full Text] [Related]
22. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals.
Matyas JR; Ehlers PF; Huang D; Adams ME
Arthritis Rheum; 1999 May; 42(5):993-1002. PubMed ID: 10323456
[TBL] [Abstract][Full Text] [Related]
23. Effect of synovitis and corticosteroids on transcription of cartilage matrix proteins.
MacLeod JN; Fubini SL; Gu DN; Tetreault JW; Todhunter RJ
Am J Vet Res; 1998 Aug; 59(8):1021-6. PubMed ID: 9706207
[TBL] [Abstract][Full Text] [Related]
24. Load-controlled compression of articular cartilage induces a transient stimulation of aggrecan gene expression.
Valhmu WB; Stazzone EJ; Bachrach NM; Saed-Nejad F; Fischer SG; Mow VC; Ratcliffe A
Arch Biochem Biophys; 1998 May; 353(1):29-36. PubMed ID: 9578597
[TBL] [Abstract][Full Text] [Related]
25. Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilage.
Olszewski JM; Moore VL; McDonnell J; Williams H; Saphos CA; Green BG; Knight WB; Chapman KT; Hagmann WK; Dorn CP; Hale JJ; Mumford RA
Connect Tissue Res; 1996; 33(4):291-9. PubMed ID: 8834447
[TBL] [Abstract][Full Text] [Related]
26. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
27. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
28. A material decoy of biological media based on chitosan physical hydrogels: application to cartilage tissue engineering.
Montembault A; Tahiri K; Korwin-Zmijowska C; Chevalier X; Corvol MT; Domard A
Biochimie; 2006 May; 88(5):551-64. PubMed ID: 16626850
[TBL] [Abstract][Full Text] [Related]
29. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
Céleste C; Ionescu M; Robin Poole A; Laverty S
J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
[TBL] [Abstract][Full Text] [Related]
30. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
[TBL] [Abstract][Full Text] [Related]
31. Serum markers of systemic disease processes in osteoarthritis.
Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
[TBL] [Abstract][Full Text] [Related]
32. Effects of proteinase inhibitors on aggrecan catabolism in chondrocyte cultures.
Flannery CR; Sandy JD
Ann N Y Acad Sci; 1994 Sep; 732():380-3. PubMed ID: 7978815
[No Abstract] [Full Text] [Related]
33. Alzheimer's disease: the proteoglycans hypothesis.
Celesia GG
Semin Thromb Hemost; 1991; 17 Suppl 2():158-60. PubMed ID: 1948087
[No Abstract] [Full Text] [Related]
34. Chondroitin sulphation in human joint tissues varies with age, zone and topography.
Bayliss MT; Davidson C; Woodhouse SM; Osborne DJ
Acta Orthop Scand Suppl; 1995 Oct; 266():22-5. PubMed ID: 8553856
[No Abstract] [Full Text] [Related]
35. Normal and shear interactions between hyaluronan-aggrecan complexes mimicking possible boundary lubricants in articular cartilage in synovial joints.
Seror J; Merkher Y; Kampf N; Collinson L; Day AJ; Maroudas A; Klein J
Biomacromolecules; 2012 Nov; 13(11):3823-32. PubMed ID: 23074968
[TBL] [Abstract][Full Text] [Related]
36. [Aggrecan].
Watanabe H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():821-3. PubMed ID: 16149651
[No Abstract] [Full Text] [Related]
37. [Polymeric chondroitin sulfate vs. monomeric glucosamine for the treatment of osteoarthritis].
Menzel EJ
Wien Med Wochenschr; 2000; 150(5):87-90. PubMed ID: 10838710
[TBL] [Abstract][Full Text] [Related]
38. Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan.
Fülöp C; Cs-Szabó G; Glant TT
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):935-40. PubMed ID: 8921002
[TBL] [Abstract][Full Text] [Related]
39. An N-terminal peptide from link protein stimulates synthesis of cartilage proteoglycans.
Liu H; McKenna LA; Dean M
Biochem Soc Trans; 1997 Aug; 25(3):427S. PubMed ID: 9388654
[No Abstract] [Full Text] [Related]
40. Glycogen-bound protein in lower eukaryote and prokaryote.
Goldraij A; Miozzo MC; Curtino JA
Biochem Mol Biol Int; 1993 Jul; 30(3):453-60. PubMed ID: 8401303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
